English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article
Jiang, XM, Xu, YL, Yuan, LW, Zhang, LL, Huang, MY, Ye, ZH, Su, MX, Chen, X. P., Zhu, H, Ye, R, Lu, J.. TGFβ2-mediated epithelial-mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance[J]. Acta Pharmacologica Sinica, 2020, 451-459.
Authors:  Jiang, XM;  Xu, YL;  Yuan, LW;  Zhang, LL;  Huang, MY; et al.
Favorite |  | Submit date：2022/08/26
Egfr Mutant Non-small Cell Lung Cancer  Nf-κb  Tgfβ2  Epithelial-mesenchymal Transition  Osimertinib Resistance  
天然產物PNE6C誘導非小細胞肺癌細胞G2期阻滯及凋亡 Conference paper
Zhang, LL, Feng, ZL, Su, MX, Lin, L., Lu, J.. 天然產物PNE6C誘導非小細胞肺癌細胞G2期阻滯及凋亡[C], 2017.
Authors:  Zhang, LL;  Feng, ZL;  Su, MX;  Lin, L.;  Lu, J.
Favorite |  | Submit date：2022/07/27
PNE6C  非小细胞肺癌  增殖  细胞周期  凋亡  
Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells Conference paper
Tang, ZH, Su, MX, Cao, WX, Chen, X. P., Lu, J.. Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells[C], 2016.
Authors:  Tang, ZH;  Su, MX;  Cao, WX;  Chen, X. P.;  Lu, J.
Favorite |  | Submit date：2022/08/26
Osimertinib  AZD9291  autophagy  apoptosis  NSCLC  
Treatment of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells by targeting inositol-requiring enzyme 1α Conference paper
Tang, ZH, Su, MX, Guo, XH, Jiang, XM, Chen, X. P., Lu, J.. Treatment of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells by targeting inositol-requiring enzyme 1α[C], 2016.
Authors:  Tang, ZH;  Su, MX;  Guo, XH;  Jiang, XM;  Chen, X. P.; et al.
Favorite |  | Submit date：2022/08/26
osimertinib  AZD9291  EGFR  IRE1α  NSCLC